Interleukin-1β Downregulates RBP4 Secretion in Human Adipocytes

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Kotnik, Primoz ^a,b   Keuper, Michaela ^a   Wabitsch, Martin ^a   Fischer Posovszky, Pamela ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; RETINOL BINDING PROTEIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; GENETIC CORRELATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INFLAMMATION; MACROPHAGE FUNCTION; MICROENVIRONMENT; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE STUDY; RBP4 GENE; TISSUE DISTRIBUTION; TRANSCRIPTION INITIATION;

ADIPOCYTES; ADIPOSE TISSUE; ADULT; CULTURE MEDIA, CONDITIONED; DOWN-REGULATION; FEMALE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; NF-KAPPA B; RECEPTORS, INTERLEUKIN-1; RETINOL-BINDING PROTEINS, PLASMA; RNA, MESSENGER; TIME FACTORS;

EID: 84874521496     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057796     Document Type: Article

References (27)

1. Maury E, Brichard SM, (2010) Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 314: 1-16.
2. Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, et al. (2007) Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care 30: 1647-1652.
3. Levy-Marchal C, Arslanian S, Cutfield W, Sinaiko A, Druet C, et al. (2010) Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab 95: 5189-5198.
4. Ouchi N, Parker JL, Lugus JJ, Walsh K, (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11: 85-97.
5. Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, et al. (2008) Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8: 301-309.
6. Flower DR, (1996) The lipocalin protein family: structure and function. Biochem J 318 (Pt 1): 1-14.
7. Friebe D, Neef M, Erbs S, Dittrich K, Kratzsch J, et al. (2011) Retinol binding protein 4 (RBP4) is primarily associated with adipose tissue mass in children. Int J Pediatr Obes 6: e345-352.
8. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, et al. (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436: 356-362.
9. Norseen J, Hosooka T, Hammarstedt A, Yore MM, Kant S, et al. (2012) Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism. Mol Cell Biol 32: 2010-2019.
10. Cho YM, Youn BS, Lee H, Lee N, Min SS, et al. (2006) Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 29: 2457-2461.
11. Lee DC, Lee JW, Im JA, (2007) Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metabolism 56: 327-331.
12. Kotnik P, Fischer-Posovszky P, Wabitsch M, (2011) RBP4: a controversial adipokine. Eur J Endocrinol 165: 703-711.
13. Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavanh B, et al. (2007) Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab 92: 2590-2597.
14. Sell H, Eckel J, (2007) Regulation of retinol binding protein 4 production in primary human adipocytes by adiponectin, troglitazone and TNF-alpha. Diabetologia 50: 2221-2223.
15. Hauner H, Skurk T, Wabitsch M, (2001) Cultures of human adipose precursor cells. Methods Mol Biol 155: 239-247.
16. Wabitsch M, Brenner RE, Melzner I, Braun M, Moller P, et al. (2001) Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord 25: 8-15.
17. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
18. Simons PJ, van den Pangaart PS, Aerts JM, Boon L, (2007) Pro-inflammatory delipidizing cytokines reduce adiponectin secretion from human adipocytes without affecting adiponectin oligomerization. J Endocrinol 192: 289-299.
19. Keuper M, Bluher M, Schon MR, Moller P, Dzyakanchuk A, et al. (2011) An inflammatory micro-environment promotes human adipocyte apoptosis. Mol Cell Endocrinol 339: 105-113.
20. Weber A, Wasiliew P, Kracht M, (2010) Interleukin-1 (IL-1) pathway. Sci Signal 3: cm1.
21. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, et al. (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354: 2552-2563.
22. Dinarello CA, (2011) Blocking interleukin-1beta in acute and chronic autoinflammatory diseases. J Intern Med 269: 16-28.
23. Bruun JM, Pedersen SB, Kristensen K, Richelsen B, (2002) Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Mol Cell Endocrinol 190: 91-99.
24. Constant VA, Gagnon A, Landry A, Sorisky A, (2006) Macrophage-conditioned medium inhibits the differentiation of 3T3-L1 and human abdominal preadipocytes. Diabetologia 49: 1402-1411.
25. Sethi JK, Hotamisligil GS, (1999) The role of TNF alpha in adipocyte metabolism. Semin Cell Dev Biol 10: 19-29.
26. Dinarello CA, (2011) Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117: 3720-3732.
27. Dinarello CA, Donath MY, Mandrup-Poulsen T, (2010) Role of IL-1beta in type 2 diabetes. Curr Opin Endocrinol Diabetes Obes 17: 314-321.